Fig. 2.
Treatment exposure and response duration of the enrolled patients. CR complete response, PD progressive disease, PR partial response, SD stable disease, VGPR very good partial response
Treatment exposure and response duration of the enrolled patients. CR complete response, PD progressive disease, PR partial response, SD stable disease, VGPR very good partial response